Gangrene treatment – new ways to cure gangrene

Gangrene treatment – new ways to cure gangrene

Gangrene is localized soft-tissue death (necrosis) from prolonged blood-supply blockage. It can occur in atherosclerosis, diabetes mellitus, or decubitus ulcer, and after severe burns or frostbite.

New research studies are finding different new ways to treat gangrene to save body parts.

Gangrene is a dreadful disease in which the profession has failed to offer much in the way of relief for these patients.

continue reading

Decaffeinated coffee preserves memory by improving brain energy

Decaffeinated coffee may improve brain energy metabolism associated with type 2 diabetes. This brain dysfunction is a known risk factor for dementia and other neurodegenerative disorders like Alzheimer’s disease.

continue reading

Top 10 Diwali SMS 2011 – happy diwali wishes sms deepavali greetings

Diwali (also spelled Devali in certain regions) or Deepavali, popularly known as the “festival of lights”, is an important festival in Hinduism, celebrated for different reasons, occurring between mid-October and mid-November.

For Hindus, Diwali is one of the most important festivals of the year and is celebrated in families by performing traditional activities together in their homes. For Jains, Diwali marks the attainment of moksha or nirvana by Mahavira in 527 BC.

continue reading

H1N1 flu :: Pandemic swine flu – H1N1 Influenza

Novel H1N1 (referred to as “swine flu” early on) is a new influenza virus causing illness in people. This new virus was first detected in people in the United States in April 2009. Other countries, including Mexico and Canada, have reported people sick with this new virus. This virus is spreading from person-to-person, probably in much the same way that regular seasonal influenza viruses spread.

Liver Cancer :: Nexavar approved for patients with inoperable liver cancer

Anticancer drug Nexavar raised survival period in inoperable hepatocellular carcinoma patients suffering from this kind of liver cancer. The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.